These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11907034)

  • 1. Structure determination of T cell protein-tyrosine phosphatase.
    Iversen LF; Moller KB; Pedersen AK; Peters GH; Petersen AS; Andersen HS; Branner S; Mortensen SB; Moller NP
    J Biol Chem; 2002 May; 277(22):19982-90. PubMed ID: 11907034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
    Rao GS; Ramachandran MV; Bajaj JS
    J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: from diabetes, obesity to cell cycle, and cancer.
    Dubé N; Tremblay ML
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):108-17. PubMed ID: 16198645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steric hindrance as a basis for structure-based design of selective inhibitors of protein-tyrosine phosphatases.
    Iversen LF; Andersen HS; Møller KB; Olsen OH; Peters GH; Branner S; Mortensen SB; Hansen TK; Lau J; Ge Y; Holsworth DD; Newman MJ; Hundahl Møller NP
    Biochemistry; 2001 Dec; 40(49):14812-20. PubMed ID: 11732900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design of a low molecular weight, nonphosphorus, nonpeptide, and highly selective inhibitor of protein-tyrosine phosphatase 1B.
    Iversen LF; Andersen HS; Branner S; Mortensen SB; Peters GH; Norris K; Olsen OH; Jeppesen CB; Lundt BF; Ripka W; Møller KB; Møller NP
    J Biol Chem; 2000 Apr; 275(14):10300-7. PubMed ID: 10744717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the molecular basis for potent and selective protein-tyrosine phosphatase 1B inhibition.
    Guo XL; Shen K; Wang F; Lawrence DS; Zhang ZY
    J Biol Chem; 2002 Oct; 277(43):41014-22. PubMed ID: 12193602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin action.
    Bleasdale JE; Ogg D; Palazuk BJ; Jacob CS; Swanson ML; Wang XY; Thompson DP; Conradi RA; Mathews WR; Laborde AL; Stuchly CW; Heijbel A; Bergdahl K; Bannow CA; Smith CW; Svensson C; Liljebris C; Schostarez HJ; May PD; Stevens FC; Larsen SD
    Biochemistry; 2001 May; 40(19):5642-54. PubMed ID: 11341829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design of selective and potent inhibitors of protein-tyrosine phosphatase beta.
    Lund IK; Andersen HS; Iversen LF; Olsen OH; Møller KB; Pedersen AK; Ge Y; Holsworth DD; Newman MJ; Axe FU; Møller NP
    J Biol Chem; 2004 Jun; 279(23):24226-35. PubMed ID: 15024017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells.
    Ottanà R; Maccari R; Mortier J; Caselli A; Amuso S; Camici G; Rotondo A; Wolber G; Paoli P
    Eur J Med Chem; 2014 Jan; 71():112-27. PubMed ID: 24287560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the hematopoietic tyrosine phosphatase (HePTP) catalytic domain: structure of a KIM phosphatase with phosphate bound at the active site.
    Mustelin T; Tautz L; Page R
    J Mol Biol; 2005 Nov; 354(1):150-63. PubMed ID: 16226275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric inhibition of protein tyrosine phosphatase 1B.
    Wiesmann C; Barr KJ; Kung J; Zhu J; Erlanson DA; Shen W; Fahr BJ; Zhong M; Taylor L; Randal M; McDowell RS; Hansen SK
    Nat Struct Mol Biol; 2004 Aug; 11(8):730-7. PubMed ID: 15258570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of human dual specificity phosphatase, JNK stimulatory phosphatase-1, at 1.5 A resolution.
    Yokota T; Nara Y; Kashima A; Matsubara K; Misawa S; Kato R; Sugio S
    Proteins; 2007 Feb; 66(2):272-8. PubMed ID: 17068812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization and crystal structure of the C215D mutant of protein-tyrosine phosphatase-1B.
    Romsicki Y; Scapin G; Beaulieu-Audy V; Patel S; Becker JW; Kennedy BP; Asante-Appiah E
    J Biol Chem; 2003 Aug; 278(31):29009-15. PubMed ID: 12748196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual PTP1B/TC-PTP Inhibitors: Biological Evaluation of 3-(Hydroxymethyl)cinnoline-4(
    Derkach KV; Gureev MA; Babushkina AA; Mikhaylov VN; Zakharova IO; Bakhtyukov AA; Sorokoumov VN; Novikov AS; Krasavin M; Shpakov AO; Balova IA
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of T cell protein tyrosine phosphatase reveals significant functional homology to protein tyrosine phosphatase-1B.
    Romsicki Y; Kennedy BP; Asante-Appiah E
    Arch Biochem Biophys; 2003 Jun; 414(1):40-50. PubMed ID: 12745253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B.
    Salmeen A; Andersen JN; Myers MP; Tonks NK; Barford D
    Mol Cell; 2000 Dec; 6(6):1401-12. PubMed ID: 11163213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structural basis for the selectivity of benzotriazole inhibitors of PTP1B.
    Scapin G; Patel SB; Becker JW; Wang Q; Desponts C; Waddleton D; Skorey K; Cromlish W; Bayly C; Therien M; Gauthier JY; Li CS; Lau CK; Ramachandran C; Kennedy BP; Asante-Appiah E
    Biochemistry; 2003 Oct; 42(39):11451-9. PubMed ID: 14516196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residue 259 in protein-tyrosine phosphatase PTP1B and PTPalpha determines the flexibility of glutamine 262.
    Peters GH; Iversen LF; Andersen HS; Møller NP; Olsen OH
    Biochemistry; 2004 Jul; 43(26):8418-28. PubMed ID: 15222753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformation-assisted inhibition of protein-tyrosine phosphatase-1B elicits inhibitor selectivity over T-cell protein-tyrosine phosphatase.
    Asante-Appiah E; Patel S; Desponts C; Taylor JM; Lau C; Dufresne C; Therien M; Friesen R; Becker JW; Leblanc Y; Kennedy BP; Scapin G
    J Biol Chem; 2006 Mar; 281(12):8010-5. PubMed ID: 16407290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTP1B and TC-PTP: regulators of transformation and tumorigenesis.
    Stuible M; Doody KM; Tremblay ML
    Cancer Metastasis Rev; 2008 Jun; 27(2):215-30. PubMed ID: 18236007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.